The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant
Completed
Conditions studied: Contraception, Obesity
In brief
Two-thirds of young women in the United States are overweight or obese. This excess weight may affect how their body metabolizes drugs such as different birth control methods. There is a not a lot of research about how excess weight could affect the hormone levels of the contraceptive implant. Methods like the implant contain only progesterone, which is a hormone that does not increase a woman's risk of blood clot. These methods would be preferred for overweight and obese women because excess weight also increases a woman's risk of blood clot. The investigators propose a study comparing blood hormone levels of women using the implant for at least twelve months and in all weight categories. The investigators hope to show that all women, regardless of weight, will have hormone levels high enough to prevent pregnancy.
Key facts
- Study ID
- NCT01855620
- Run by
- Columbia University
- People needed
- 52
- Starts
- 2012-12-01
- Expected to finish
- 2014-03-01
- Last updated by the study team
- 2014-04-14
Who can join
Age: any. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Woman using contraceptive implant for more than 12 months
- English or Spanish-speaking
You may not qualify if…
- None
Where it is running
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.